drugset / Trial / NCT04219332

Randomized Controlled Trial on Effect of Lymph Node Mapping by Indocyanine Green Via Submucosal or Subserosal Injection

NCT04219332

Phase 3 Unknown 266 enrolled Fujian Medical University
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study was to evaluate whether submucosal or subserous injection of indocyanine green during laparoscopic lymphadenectomy for patients with gastric cancer was different. The patients with gastric adenocarcinoma (cT1-4a, N0/+, M0) were studied.

Timeline

Start
2019-12-31
Primary completion
2020-11-27
Completion
2023-10-28

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent 2.5 mg Other
Subject Indocyanine Green Diagnostic / imaging agent 4.5 mg Other

Indications